Congratulations to Dr Christopher Grigsby, who has been awarded a Whitaker International Fellowship, entitled “Nonviral reprogramming of fibroblasts to dopaminergic neurons: cell therapy for Parkinson’s disease”, to join the Stevens Group. Congrats Chris!